KABANAT 60MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹6395.68

NATCO PHARMA LTD (ONCOLOGY DIV): Kabanat 60MG Injection, 1 vial, salt cabazitaxel 60mg. NPPA has revised its MRP from Rs 11,269.41 to Rs 6,395.68 (43% lower) with effect from 09-11-2026; trade rate Rs 4,872.90. Group: taxane chemotherapy. No other manufacturer of this salt and strength is listed here yet. Handling/counselling: IV infusion with premedication and often G-CSF support; cytotoxic: handle and dispose of as hazardous waste. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.